PP_1170x120_10-25-21

Hy-Vee

New pediatric COVID-19 boosters available at select Hy-Vee Pharmacies

New pediatric COVID-19 boosters available at select Hy-Vee Pharmacies

WEST DES MOINES, Iowa — Hy-Vee, Inc. announced that a limited supply of the new pediatric COVID-19 boosters are now available at select Hy-Vee Pharmacy locations by appointment. Also known as “bivalent boosters,” the new COVID-19 boosters are reformulated to target versions of the latest Omicron subvariants including BA.4 and BA.5, along with the original

Hy-Vee providing free Medicare plan comparisons

Hy-Vee providing free Medicare plan comparisons

WEST DES MOINES, Iowa — Hy-Vee Medicare Aisle is providing free Medicare plan comparisons during Medicare’s Annual Open Enrollment Period (AEP), which began Saturday, October 15, and ends Wednesday, December 7, the retailer said. The Centers for Medicare and Medicaid Services (CMS) recommends all Medicare participants review their coverage each year to make sure their

Hy-Vee dietitians hosting gluten-free awareness month events in October

Hy-Vee dietitians hosting gluten-free awareness month events in October

WEST DES MOINES, Iowa — Throughout October, Hy-Vee’s team of registered dietitians will host events focused on gluten-free lifestyles through a variety of programming. Events will include virtual cooking classes and store tours, as well as an in-person, gluten-free health fair at select stores. Gluten-Free Health Fair A free in-person, gluten-free health fair will be held

Hy-Vee makes major commitment to fight hunger at White House Conference

Hy-Vee makes major commitment to fight hunger at White House Conference

WEST DES MOINES, Iowa — At today’s White House Conference on Hunger, Nutrition and Health in Washington, D.C., Hy-Vee chairman and CEO Randy Edeker stated that the company will deliver 30 million meals to vulnerable communities by 2025, as well as deploy its registered dietitian team to educate 100,000 Americans in areas of low food

Hy-Vee earns U.S. EPA’s GreenChill recognition

Hy-Vee earns U.S. EPA’s GreenChill recognition

WEST DES MOINES, Iowa  — Hy-Vee, Inc. has earned a GreenChill recognition from the U.S. Environmental Protection Agency (EPA) for its work to reduce refrigerant emissions and decrease its environmental impact. Hy-Vee was honored with the GreenChill recognition for Superior Goal Achievement, awarded to GreenChill partners that achieve their annual GreenChill refrigerant emissions reduction goal. EPA’s

Edeker sets the stage For Hy-Vee’s future

Edeker sets the stage For Hy-Vee’s future

WEST DES MOINES, Iowa — Randy Edeker has had a remarkable run at Hy-Vee. Under his leadership as chairman and chief executive officer of the Midwestern grocer, the company extended its reach from food retailing and pharmacy to include other health and wellness services, e-commerce, restaurants and distribution. In the process, sales nearly doubled and

Hy-Vee Sets ‘Best of Local Brands’ Summit

Hy-Vee Sets ‘Best of Local Brands’ Summit

WEST DES MOINES, Iowa — Hy-Vee, Inc. is accepting submissions from suppliers of local brands ahead of the retailer’s next “Best of Local Brands” summit” in November. The summit consists of 20-minute virtual interviews with selected suppliers and will take place November 2 through November 4. Submissions are made online through RangeMe, the online product

Hy-Vee CEO Randy Edeker names successor

Hy-Vee CEO Randy Edeker names successor

WEST DES MOINES, Iowa — Hy-Vee chairman and CEO Randy Edeker has named Aaron Wiese as Hy-Vee’s next CEO, effective Oct. 1, 2022. Wiese is currently vice chairman of Hy-Vee, Inc. and president of the company’s supply chain and subsidiaries. Jeremy Gosch will remain as president and chief operating officer of Hy-Vee, overseeing all of

Hy-Vee Pharmacy now offering test-to-treat COVID-19 services

Hy-Vee Pharmacy now offering test-to-treat COVID-19 services

WEST DES MOINES, Iowa —Hy-Vee, Inc. announced this week that all Hy-Vee Pharmacy locations across its eight-state region now offer test-to-treat COVID-19 services using the COVID-19 antiviral, Paxlovid, to help treat mild-to-moderate cases of COVID-19 in certain patients who are at high risk for progression to severe COVID-19. Earlier this month, the FDA authorized state-licensed

1 2 3 12
Adheris Health